OBI Pharma, Inc.
Stock Code: 4174.TWO
Market: Taipei Exchange
Industry Type: Biotech & Medical Care
Principal Activities: New drugs research
Date of Establishment: 2002/04/29
Date of Listing: 2015/03/23
Chairman: Kung-Yee Liang
Stock Transfer Agent: MasterLink Securities Corporation
Auditors: PricewaterhouseCoopers Taiwan
Principal Office: 6F., No.508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City, Taiwan
Tel: (02) 2655-8799
Fax: (02) 2786-3358
E-mail: info@obipharma.com
Website: www.obipharma.com/